Emergent BioSolutions, Inc. (EBS)
8.15
+0.09
(+1.12%)
USD |
NYSE |
May 20, 16:00
8.10
-0.05
(-0.61%)
After-Hours: 19:36
Emergent BioSolutions Total Liabilities (Quarterly) : 797.30M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Savara, Inc. | 45.61M |
| Biogen, Inc. | 10.83B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.320B |
| Shareholders Equity (Quarterly) | 523.10M |
| Debt to Equity Ratio | 1.214 |
| Current Ratio | 4.288 |
| Net Debt Paydown Yield | 1.91% |